Carboplatin Research

Despite having been used widely for over 15 years, carboplatin and similar drugs continue to inspire quite a bit of scientific research.

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

FTY720 enhances the efficacy of paclitaxel and of carboplatin in drug-resistant ovarian cancer cells

Delayed nausea and vomiting from carboplatin doublet chemotherapy

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

Neoadjuvant chemotherapy with docetaxel, carboplatin and weekly trastuzumab (TCH) is active in HER2-positive early breast cancer: Results after a median follow-up of over 4 years

Nonrandomized comparison of neurofibromatosis type 1 and non–neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma

Genetic association of gemcitabine/carboplatin induced myelosuppression in patients with non-small cell lung cancer using whole exome sequencing

FTY720 enhances the efficacy of paclitaxel and of carboplatin in drug-resistant ovarian cancer cells

Delayed nausea and vomiting from carboplatin doublet chemotherapy

Neoadjuvant chemotherapy with docetaxel, carboplatin and weekly trastuzumab (TCH) is active in HER2-positive early breast cancer: Results after a median follow-up of over 4 years

Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)

Delayed nausea and vomiting from carboplatin doublet chemotherapy

Report on four-drug combination therapy success.

A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance.

Report spells out ototoxic risks of platinum-based chemotherapy and radiotherapy

Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.

Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma.

Does weight matter in determining dosage?

DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells

Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

Does a nanomolecule of Carboplatin injected periocularly help in attaining higher intravitreal concentrations?

Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.

Single-dose carboplatin as effective as radiation for early testicular cancer

Advanced Cervical Cancer Can Be Successfully Downstaged With Pre-Surgery Carboplatin And Docetaxel

Advances in platinum chemotherapy from RSC

Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.